BNP Paribas Discount Zert MRNA 27.../ DE000PN53VS3 /

24/05/2024 21:40:19	Chg.-0.330	Bid21:53:57	Ask21:53:57	Underlying	Strike price	Expiration date	Option type
100.820EUR	-0.33%	100.830 Bid Size: 1,900	100.880 Ask Size: 1,900	Moderna Inc	- USD	27/06/2024	Call

GlobeNewswire 22/05 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

GlobeNewswire 22/05 Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...

TeleTrader 20/05 Dow slumps 195 points at closing bell after corporate news

GlobeNewswire 16/05 CytomX Therapeutics Announces New Employment Inducement Grants

TeleTrader 13/05 Wall Street closes mixed ahead of key inflation data

GlobeNewswire 12/05 TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...

GlobeNewswire 08/05 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 08/05 Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...

TeleTrader 02/05 US surges at close as traders weigh Fed remarks

TeleTrader 02/05 Moderna surges 9% as Q1 revenue beat expectations

GlobeNewswire 02/05 Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update

TeleTrader 02/05 Moderna sees $167M in Q1 revenue, beats forecasts

TeleTrader 02/05 US higher premarket after Fed's decision

GlobeNewswire 01/05 Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems

GlobeNewswire 01/05 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...

TeleTrader 24/04 Moderna, OpenAI partner on mRNA medicine advancement

TeleTrader 09/04 US markets close mostly higher ahead of inflation report

GlobeNewswire 04/04 Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...

TeleTrader 28/03 US closes mixed amid data

TeleTrader 26/03 Wall Street closes lower after economic data

GlobeNewswire 21/03 Immatics Announces Full Year 2023 Financial Results and Corporate Update

GlobeNewswire 11/03 CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update

GlobeNewswire 04/03 CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

GlobeNewswire 29/02 Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update

GlobeNewswire 27/02 CytomX Therapeutics to Present at Upcoming March Investor Conferences